Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Researchers talking with patients

    Parkinson's Inosine Trial Ending Early

    An interim analysis concluded that the SURE-PD3 trial is unlikely to determine that inosine can slow Parkinson's progression. The trial therefore is ending earlier than planned.
    Learn more
  • Research Testing

    Alkahest Begins Phase II Trial of Plasma-Based Therapy

    As we age, the quality of our plasma and its proteins can degrade, which may contribute to problems that damage our brain cells and affect cognition.
    Learn more
  • Fox Insight logo

    Fox Insight Brings Patient Perspective to Parkinson's Drug Development

    At a meeting with the FDA, patients, researchers, clinicians, drug makers and nonprofits, MJFF discussed Fox Insight and the role of technology in drug development to help capture patient…
    Learn more
  • Alpha-Synuclein

    A Roadmap for Alpha-Synuclein

    In 2017, MJFF convened leaders from academia and industry to form the Alpha-Synuclein Clinical Path Working Group to lay out a roadmap to advance drugs for this target.
    Learn more
  • Beakers with MJFF logos

    What We Fund: $8 Million in New Grants for Parkinson's Research

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
    Learn more
  • The Michael J. Fox Foundation's Podcast

    Podcast: Research Year in Review and Look Ahead

    Listen to our expert panelists discuss the progress made in PD research over the last year and what to look forward to in 2019.
    Learn more
  • Gene Mapping

    MJFF Funding First-in-Human Parkinson's Brain Imaging Study

    Biopharmaceutical company AC Immune is testing its tool to show alpha-synuclein on brain scans, which could help diagnose and track Parkinson's and measure therapeutic impact.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year